“The risk of not getting involved is that the most expert voices will not be heard.
And then, the policies we have to live with won’t reflect what we know is best for our patients.” 
 

Clifford A. Hudis, MD, FACP, FASCO
ASCO Chief Executive Officer

asco advocacy summit 2026

NNECOS leaders represented Maine, New Hampshire and Vermont during the Association for Clinical Oncology (ASCO) annual Advocacy Summit from April 20-21. Representatives spoke with congressional staffers about the following priority issues:

  • Support federally funded cancer research – support consistent funding for the NIH, NCI, and ARPA-H in FY2027. Strategic investment and predictable funding are critical to ensure the continuity and success of research, preventing both the loss of momentum and squandering prior investments.
  • Reform prior authorization mandates – Help reform prior authorization and improve patient care by passing the Improving Seniors’ Timely Access to Care Act. This bipartisan House and Senate legislation would streamline prior authorization in Medicare Advantage, hold plans accountable for their prior authorization mandates, and improve transparency.
  • Extend telehealth flexibilities – Permanently extend Medicare telehealth flexibilities and strengthen patient access to cancer care by passing the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, bipartisan House and Senate legislation. For those facing a cancer diagnosis, telehealth is more than a convenience: it is necessary for maintaining uninterrupted access to high-quality care.

The Week of Action was held in conjunction with the annual ASCO Advocacy Summit, on Capitol Hill in Washington, D.C. During the event, oncology care providers from across the United States met with Members of Congress and their staff to advocate for the Association’s advocacy priorities.